Improving crop yields in a world of extreme weather
“If you can control the receptors the way ABA does, then you have a way to control water loss and drought-tolerance,” Cutler said. “It has been known for many years that simply spraying ABA on plants improves their water use and stress tolerance, but ABA itself is much too expensive for practical use in the field by farmers.”
To address this problem, Cutler and his team searched through many thousands of molecules to identify inexpensive synthetic chemicals that could activate the receptors by mimicking ABA. The team found and named quinabactin, a molecule they show is almost indistinguishable from ABA in its effects, but much simpler chemically and therefore easier to make than ABA. By studying how the new molecule activates the ABA receptors that are involved in drought tolerance, the team also has learned more about the underlying control logic of the stress response system and provided new information that can be used for others interested in developing similar molecules,
“This is a competitive arena that includes agrichemical giants who are busily working to bring similar drought-protecting molecules to market, so this is a landmark discovery because quinabactin is the first-in-class synthetic molecule of its kind,” Cutler said.
The work reported this week is the first in a multistep process of bringing a new agricultural product to market. Given the complexity and costs of such a process, the UCR Office of Technology Commercialization (OTC) is working with an agricultural leader, Syngenta Biotechnology, Inc., to develop the technology.
Joyce Patrona, a licensing officer in OTC, is coordinating UCR’s licensing efforts for quinabactin.
“It has become very apparent to industry engaged in this area of technology of the robustness of Dr. Cutler’s research,” she said. “This is a credit to Dr. Cutler and his team as well as to UCR for its commitment to bring innovative research to the marketplace.”
Cutler’s collaborators on the research project are Brian Volkman and Francis Peterson at the Medical College of Wisconsin, who helped unravel the mechanism by which quinabactin mimics ABA by determining the atomic structure of the new molecule bound to one of its cellular receptors. Others who worked with them are Masanori Okamoto (first author of the research paper), Andrew Defries and Sang-Youl Park at UCR; and Akira Endo and Eiji Nambara at the University of Toronto, Canada.
- China adopts stricter pesticide residue standard
- Researchers target soybean disease with genetic resistance study
- K-State Cropping Systems Field Day Set Aug. 28 in Garden City
- Ag markets ended the week in mixed fashion
- Ag turned decidedly mixed Friday morning
- Fall armyworm moth capture sees big jump
- Don’t link bird decline and use of neonicotinoids
- Solar energy jobs increase, wind power decrease
- Comments end for Enlist Duo but not the fight
- Setting the record straight on 'Waters of the U.S.'
- Commentary: Setting the record straight on 'Waters of the U.S.'
- Look at fertilizer pricing 2013 vs. 2014